Loading...
Imunon, Inc.
CLSN•NASDAQ
Healthcare
Biotechnology
$1.95
$-0.01(-0.68%)
Imunon, Inc. (CLSN) Financial Performance & Income Statement Overview
Review Imunon, Inc.’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Revenue Growth
0.00%
Operating Income Growth
-90875.06%
↓ 90875.06%
Net Income Growth
-95315.14%
↓ 95315.14%
Operating Cash Flow Growth
-99021.14%
↓ 99021.14%
Operating Margin
0.00%
Gross Margin
0.00%
Net Profit Margin
0.00%
ROE
-428.00%
↓ 428.00%
ROIC
-1714.83%
↓ 1714.83%
Imunon, Inc. (CLSN) Income Statement & Financial Overview
Review Imunon, Inc.'s (CLSN) income statement with detailed quarterly and annual figures.
| Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|
| Revenue | $727160.00 | $0.00 | $0.00 | $0.00 |
| Cost of Revenue | $363580.00 | $0.00 | $185270.00 | $178310.00 |
| Gross Profit | $363580.00 | $0.00 | -$185270.00 | -$178310.00 |
| Gross Profit Ratio | $0.50 | $0.00 | $0.00 | $0.00 |
| R&D Expenses | $11.63B | $3.29M | $2.82M | $3.29M |
| SG&A Expenses | $7.49B | $1.67M | $2.008M | $1.54M |
| Operating Expenses | $19.12B | $4.96M | $4.83M | $4.83M |
| Total Costs & Expenses | $19.12B | $4.96M | $5.01M | $5.01M |
| Interest Income | -$361263.00 | $115992.00 | $89884.00 | $155387.00 |
| Interest Expense | $0.00 | $0.00 | $0.00 | $0.00 |
| Depreciation & Amortization | -$552830.00 | $189250.00 | $185270.00 | $178310.00 |
| EBITDA | -$13.77B | -$4.66M | -$4.60M | -$4.75M |
| EBITDA Ratio | -$18930.82 | $0.00 | $0.00 | $0.00 |
| Operating Income | -$19.12B | -$4.96M | -$5.01M | -$5.01M |
| Operating Income Ratio | -$26290.58 | $0.00 | $0.00 | $0.00 |
| Other Income/Expenses (Net) | $5.35B | -$4.84B | $225334.00 | $81921.00 |
| Income Before Tax | -$13.77B | -$4.85B | -$4.79M | -$4.93M |
| Income Before Tax Ratio | -$18929.88 | $0.00 | $0.00 | $0.00 |
| Income Tax Expense | -$135034.00 | $0.00 | $0.00 | $135034.00 |
| Net Income | -$13.77B | -$4.85B | -$4.79M | -$4.93M |
| Net Income Ratio | -$18929.88 | $0.00 | $0.00 | $0.00 |
| EPS | $421.89 | -$335.44 | -$0.51 | -$0.52 |
| Diluted EPS | $421.89 | -$335.44 | -$0.51 | -$0.52 |
| Weighted Avg Shares Outstanding | $11.51M | $14.45M | $9.40M | $9.40M |
| Weighted Avg Shares Outstanding (Diluted) | $11.51M | $14.45M | $9.40M | $9.40M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan